Dr. Daniel J. Cole, MD

Dr. Cole practices at UPMC Passavant-McCandless in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Cole's NPI, 1477539062, was assigned on December 16, 2005. Dr. Cole graduated from Sidney Kimmel Medical College in 1984. Dr. Cole holds Pennsylvania license MD034701E.

Dr. Cole's primary practice is UPMC Passavant-McCandless, at 9100 Babcock Boulevard, Pittsburgh, PA 15237 in Allegheny County. The practice phone is (412) 367-6700.

Dr. Cole's primary practice is UPMC Passavant-McCandless in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Cole is also affiliated with UPMC Magee-Womens Hospital. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Cole to 3 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cole practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Cole's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Cole is board certified in urology by the American Board of Urology. Dmand AI has Dr. Cole's licenses on file in 2 states: Pennsylvania and West Virginia.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Cole treats.

CMS data shows 1,200 Medicare services from Dr. Cole across 16 procedure codes in 2024, for 441 Medicare patients. Medicare paid $69,114 for them.

CMS counts 441 Medicare patients who saw Dr. Cole in 2024. The largest group is 65 to 74, with 244 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Cole's median patient age at 75, with 10% women.

In 2024, Dr. Cole wrote 3,314 Medicare Part D claims for 741 patients. 99% of them were for generic drugs. CMS names the drug for 3,166 of them, across 17 drugs with 11 or more claims each, at $77,964 in total drug cost. In 2023, CMS named 3,065 claims across 20 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Cole for performance year 2024, reported as part of a group. Dr. Cole accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Hernia repair (minimally invasive): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Cole, published from 2021 to 2025. 2025 was the busiest year, with 2. Dr. Cole's most frequent co-authors are Maxime Cannesson, MD, James Phillip Rathmell, MD and Amr E. Abouleish, MD.

CMS Open Payments shows 14 general payments to Dr. Cole from 10 drug and device companies from 2016 to 2025. Ownership or investment make up the largest share, 91% of the total. Innovative Medical Technologies, LLC paid the most, $5,237.

Dr. Cole graduated from Sidney Kimmel Medical College in 1984.

Dr. Cole is in network with 17 carriers, including Aetna, Blue Cross Blue Shield of Michigan and HCSC. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.